Streetbeat News

Earnings

ADTH

AdTheorent Holding projects its 2024 revenue to be between $188 million and $195 million, surpassing the estimated $183.649 million.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:48 pm

VERI

Veritone forecasts its Q1 revenue to be between $30.5M and $31.5M, slightly below the estimated $31.42M. For FY24, the company expects revenue to range from $134M to $142M, which is around the $135.83M estimate.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:46 pm

EML

Eastern Co (NASDAQ:EML) reported a significant increase in Q4 EPS to $0.56, up from $0.11 YoY, despite a slight decrease in sales to $67.00M from $69.10M YoY.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:45 pm

NATR

Nature's Sunshine projects its full year 2024 net sales to be between $455M and $480M, with an estimated average of $464.277M. The company also forecasts its adjusted EBITDA for the same period to be in the range of $42M to $48M.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:45 pm

CSBR

Champions Oncology (NASDAQ:CSBR) reported Q3 earnings with an EPS of $-0.16, missing estimates by -7%, and a revenue decrease of $754k from the previous year. Despite beating EPS estimates last quarter, this marks a downturn in their financial performance.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 8:45 pm

INVE

Identiv forecasts Q1'2024 net revenues to be between $22M-$24M, below the estimated $26.767M. The company anticipates normal seasonality to continue.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:43 pm

CLOV

Clover Health Investments Corp (NASDAQ:CLOV) reported Q4 sales of $510.3 million, surpassing analyst estimates and marking a significant improvement in Adjusted EBITDA. The company anticipates 2024 insurance revenue between $1.25 billion and $1.3 billion, reflecting confidence in its business model and future prospects. Shares rallied after-hours following the announcement.

Portfolio Pulse from Erica Kollmann

March 12, 2024 | 8:43 pm

LUNA

Luna Innovations shares are trading lower following the announcement of a delay in the release of its Q4 and FY23 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:41 pm

CSBR

Champions Oncology (NASDAQ:CSBR) reported Q3 losses of $(0.16) per share, missing the $(0.15) estimate, and sales of $12.02M, missing the $13.48M estimate. This represents a 6.67% miss on EPS and a 10.84% miss on sales, with a 5.90% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:41 pm

LSF

Laird Superfood (AMEX:LSF) reported Q4 sales of $9.200M, surpassing the analyst consensus estimate of $8.736M by 5.31% and marking a 2.56% increase over the previous year's sales of $8.970M.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:40 pm